Intubation-mediated intratracheal (IMIT) instillation: a noninvasive, lung-specific delivery system

• Published in: Journal of visualized experiments 2014-11 (93), p.e52261-e52261
• Main Authors: Lawrenz, Matthew B, Fodah, Ramy A, Gutierrez, Maria G, Warawa, Jonathan
• Format: Article
• Language: English
• Subjects: Administration, Intranasal; Animals; Disease Models, Animal; Humans; Instillation, Drug; Intubation, Intratracheal - methods; Lung - physiology; Medicine; Mice; Reproducibility of Results; Respiratory Tract Diseases - diagnosis; Respiratory Tract Diseases - pathology; Trachea - physiology
• ISSN: 1940-087X; 1940-087X
• DOI: 10.3791/52261

Respiratory disease studies typically involve the use of murine models as surrogate systems. However, there are significant physiologic differences between the murine and human respiratory systems, especially in their upper respiratory tracts (URT). In some models, these differences in the murine nasal cavity can have a significant impact on disease progression and presentation in the lower respiratory tract (LRT) when using intranasal instillation techniques, potentially limiting the usefulness of the mouse model to study these diseases. For these reasons, it would be advantageous to develop a technique to instill bacteria directly into the mouse lungs in order to study LRT disease in the absence of involvement of the URT. We have termed this lung specific delivery technique intubation-mediated intratracheal (IMIT) instillation. This noninvasive technique minimizes the potential for instillation into the bloodstream, which can occur during more invasive traditional surgical intratracheal infection approaches, and limits the possibility of incidental digestive tract delivery. IMIT is a two-step process in which mice are first intubated, with an intermediate step to ensure correct catheter placement into the trachea, followed by insertion of a blunt needle into the catheter to mediate direct delivery of bacteria into the lung. This approach facilitates a >98% efficacy of delivery into the lungs with excellent distribution of reagent throughout the lung. Thus, IMIT represents a novel approach to study LRT disease and therapeutic delivery directly into the lung, improving upon the ability to use mice as surrogates to study human respiratory disease. Furthermore, the accuracy and reproducibility of this delivery system also makes it amenable to Good Laboratory Practice Standards (GLPS), as well as delivery of a wide range of reagents which require high efficiency delivery to the lung.